TIP120B, also known as CAND1 (Cullin-associated and neddylation-dissociated 1), plays a critical role in the regulation of the ubiquitin-proteasome system by interacting with cullin-RING ubiquitin ligases (CRLs). These E3 ligases are essential for targeting specific substrates for ubiquitination, leading to their degradation by the proteasome. TIP120B's function is integral in the regulation of CRLs, affecting key cellular processes such as cell cycle control, signal transduction, and gene expression. By binding to unneddylated cullins, TIP120B prevents premature assembly of CRL complexes, thereby controlling the timing and specificity of substrate ubiquitination. This mechanism is crucial for the precise regulation of protein turnover in the cell, ensuring proper cellular function and response to external stimuli.
Inhibition of TIP120B disrupts this critical regulatory mechanism, leading to altered CRL activity and, consequently, imbalances in protein ubiquitination and degradation. Without the inhibitory action of TIP120B on unneddylated cullins, CRLs may become constitutively active or fail to disassemble after substrate ubiquitination, resulting in either the degradation of non-target proteins or the stabilization of proteins meant to be degraded. This disruption can affect various cellular processes, including those critical for cell division, DNA repair, and signal transduction, potentially leading to unregulated cell growth, genomic instability, and altered cellular signaling. The general mechanisms of TIP120B inhibition involve blocking its interaction with cullins or interfering with its ability to regulate the neddylation cycle. By preventing TIP120B from performing its role as a regulatory factor, the precise control over the ubiquitin-proteasome system is compromised, highlighting the importance of TIP120B in maintaining cellular homeostasis through its inhibition of CRL activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $280.00 | 1 | |
MLN4924 inhibits NEDD8-activating enzyme, which can indirectly affect CAND1 function by altering cullin neddylation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib is a proteasome inhibitor that can alter protein degradation pathways indirectly influencing CAND1-associated complexes. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132 is a proteasome inhibitor, which can result in the stabilization of proteins targeted by CAND1-regulated ubiquitin ligases. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
Lactacystin is another proteasome inhibitor that can indirectly affect CAND1 function by preventing the degradation of ubiquitinated proteins. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin has been shown to inhibit the proteasome, which may impact CAND1 indirectly by altering protein turnover. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Disulfiram can affect the ubiquitin-proteasome system, possibly altering the function of CAND1-associated degradation pathways. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $155.00 | 6 | |
Celastrol is a proteasome inhibitor that can perturb the ubiquitin-proteasome system, potentially influencing CAND1 activity. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $127.00 $572.00 $4090.00 $20104.00 | 20 | |
Withaferin A is known to inhibit the proteasomal activity, which may indirectly affect the function of CAND1. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $134.00 $215.00 $440.00 $496.00 | 19 | |
Epoxomicin is a selective proteasome inhibitor that could affect CAND1 function by altering proteasomal degradation. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $40.00 | ||
Carfilzomib, a proteasome inhibitor, can impact the degradation pathways regulated by CAND1. |